Your browser doesn't support javascript.
loading
Scaffold Hopping and Optimization of Small Molecule Soluble Adenyl Cyclase Inhibitors Led by Free Energy Perturbation.
Sun, Shan; Fushimi, Makoto; Rossetti, Thomas; Kaur, Navpreet; Ferreira, Jacob; Miller, Michael; Quast, Jonathan; van den Heuvel, Joop; Steegborn, Clemens; Levin, Lonny R; Buck, Jochen; Myers, Robert W; Kargman, Stacia; Liverton, Nigel; Meinke, Peter T; Huggins, David J.
Afiliación
  • Sun S; Tri-Institutional Therapeutics Discovery Institute, New York, New York 10021, United States.
  • Fushimi M; Tri-Institutional Therapeutics Discovery Institute, New York, New York 10021, United States.
  • Rossetti T; Department of Pharmacology, Weill Cornell Medicine, New York City, New York 10056, United States.
  • Kaur N; Department of Pharmacology, Weill Cornell Medicine, New York City, New York 10056, United States.
  • Ferreira J; Department of Pharmacology, Weill Cornell Medicine, New York City, New York 10056, United States.
  • Miller M; Tri-Institutional Therapeutics Discovery Institute, New York, New York 10021, United States.
  • Quast J; Department of Biochemistry, University of Bayreuth, Bayreuth 95440, Germany.
  • van den Heuvel J; Helmholtz-Zentrum für Infektionsforschung, Braunschweig 38124, Germany.
  • Steegborn C; Department of Biochemistry, University of Bayreuth, Bayreuth 95440, Germany.
  • Levin LR; Department of Pharmacology, Weill Cornell Medicine, New York City, New York 10056, United States.
  • Buck J; Department of Pharmacology, Weill Cornell Medicine, New York City, New York 10056, United States.
  • Myers RW; Tri-Institutional Therapeutics Discovery Institute, New York, New York 10021, United States.
  • Kargman S; Tri-Institutional Therapeutics Discovery Institute, New York, New York 10021, United States.
  • Liverton N; Tri-Institutional Therapeutics Discovery Institute, New York, New York 10021, United States.
  • Meinke PT; Tri-Institutional Therapeutics Discovery Institute, New York, New York 10021, United States.
  • Huggins DJ; Department of Pharmacology, Weill Cornell Medicine, New York City, New York 10056, United States.
J Chem Inf Model ; 63(9): 2828-2841, 2023 05 08.
Article en En | MEDLINE | ID: mdl-37060320
ABSTRACT
Free energy perturbation is a computational technique that can be used to predict how small changes to an inhibitor structure will affect the binding free energy to its target. In this paper, we describe the utility of free energy perturbation with FEP+ in the hit-to-lead stage of a drug discovery project targeting soluble adenyl cyclase. The project was structurally enabled by X-ray crystallography throughout. We employed free energy perturbation to first scaffold hop to a preferable chemotype and then optimize the binding affinity to sub-nanomolar levels while retaining druglike properties. The results illustrate that effective use of free energy perturbation can enable a drug discovery campaign to progress rapidly from hit to lead, facilitating proof-of-concept studies that enable target validation.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Adenilil Ciclasas / Descubrimiento de Drogas Idioma: En Revista: J Chem Inf Model Asunto de la revista: INFORMATICA MEDICA / QUIMICA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Adenilil Ciclasas / Descubrimiento de Drogas Idioma: En Revista: J Chem Inf Model Asunto de la revista: INFORMATICA MEDICA / QUIMICA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos